APB 104
Alternative Names: APB-104Latest Information Update: 30 Jun 2023
At a glance
- Originator Apic Bio
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Amyotrophic lateral sclerosis
Most Recent Events
- 26 Jun 2023 Early research in Amyotrophic lateral sclerosis in USA (Parenteral) before June 2023 (Apic Bio pipeline,June 2023)